Tisack A, Mohammad T
Drugs. 2024; 84(9):1071-1091.
PMID: 39085684
DOI: 10.1007/s40265-024-02062-z.
Yadav S, Gandhi V, Sharma S
Indian Dermatol Online J. 2024; 15(2):334-336.
PMID: 38550829
PMC: 10969233.
DOI: 10.4103/idoj.idoj_160_23.
Hinojosa J, Williams C, Vandergriff T, Le L
JAAD Case Rep. 2018; 4(1):72-74.
PMID: 29387754
PMC: 5771772.
DOI: 10.1016/j.jdcr.2017.11.008.
Bauer A
Hautarzt. 2016; 67(11):884-890.
PMID: 27680010
DOI: 10.1007/s00105-016-3877-0.
Egiebor E, Tulu A, Abou-Zeid N, Aighewi I, Ishaque A
Int J Environ Res Public Health. 2013; 10(10):5209-20.
PMID: 24157516
PMC: 3822392.
DOI: 10.3390/ijerph10105209.
Tpl2 is a key mediator of arsenite-induced signal transduction.
Lee K, Lee K, Bode A, Lee H, Dong Z
Cancer Res. 2009; 69(20):8043-9.
PMID: 19808956
PMC: 2830613.
DOI: 10.1158/0008-5472.CAN-09-2316.
Interventions for preventing non-melanoma skin cancers in high-risk groups.
Bath-Hextall F, Leonardi-Bee J, Somchand N, Webster A, Delitt J, Perkins W
Cochrane Database Syst Rev. 2007; (4):CD005414.
PMID: 17943854
PMC: 10799667.
DOI: 10.1002/14651858.CD005414.pub2.
Inorganic arsenic compounds cause oxidative damage to DNA and protein by inducing ROS and RNS generation in human keratinocytes.
Ding W, Hudson L, Liu K
Mol Cell Biochem. 2005; 279(1-2):105-12.
PMID: 16283519
DOI: 10.1007/s11010-005-8227-y.
Urinary trivalent methylated arsenic species in a population chronically exposed to inorganic arsenic.
Valenzuela O, Borja-Aburto V, Garcia-Vargas G, Cruz-Gonzalez M, Garcia-Montalvo E, Calderon-Aranda E
Environ Health Perspect. 2005; 113(3):250-4.
PMID: 15743710
PMC: 1253747.
DOI: 10.1289/ehp.7519.
The zinc finger transcription factor Egr-1 is upregulated in arsenite-treated human keratinocytes.
Al-Sarraj A, Thiel G
J Mol Med (Berl). 2004; 82(8):530-8.
PMID: 15292961
DOI: 10.1007/s00109-004-0545-0.
Oxidative mechanism of arsenic toxicity and carcinogenesis.
Shi H, Shi X, Liu K
Mol Cell Biochem. 2004; 255(1-2):67-78.
PMID: 14971647
DOI: 10.1023/b:mcbi.0000007262.26044.e8.
Molecular mechanisms of arsenic carcinogenesis.
Huang C, Ke Q, Costa M, Shi X
Mol Cell Biochem. 2004; 255(1-2):57-66.
PMID: 14971646
DOI: 10.1023/b:mcbi.0000007261.04684.78.
Arsenic carcinogenicity: relevance of c-Src activation.
Simeonova P, Luster M
Mol Cell Biochem. 2002; 234-235(1-2):277-82.
PMID: 12162444
Effect of arsenic, cadmium and lead on the induction of apoptosis of normal human mononuclear cells.
de la Fuente H, Portales-Perez D, Baranda L, Diaz-Barriga F, Layseca E, Gonzalez-Amaro R
Clin Exp Immunol. 2002; 129(1):69-77.
PMID: 12100024
PMC: 1906410.
DOI: 10.1046/j.1365-2249.2002.01885.x.
